Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

GSK-3β, human recombinant

based on 1 citations in multiple journalsGSK-3β, human recombinant14.1 4
A phosphorylating and an inactivating agent of glycogen synthase
Catalog #: 7004
SKU-Size Size Price Qty
7004-10 10 μg
7004-100 100 μg
7004-1000 1 mg
More Sizes Get Quote

Product Details

Alternate Name GSK, Glycogen synthase kinase-3 (GSK-3)
Gene Symbol GSK3B
Gene ID 2932
Accession # P49841
Source E. coli.
Appearance Lyophilized powder
Physical Form Description Lyophilized from 2 mg/ml in 0.1 M NH4CO3
Molecular Weight 53.0-56.0 kDa
Purity by SDS-PAGE ≥90%
Reconstitution Instructions Reconstitute to 1 mg/ml in PBS containing 15% glycerol. The solution should be stored at –70°C, stable for up to 3 months.
Handling Centrifuge the vial prior to opening.
Storage Conditions -70°C
Shipping Conditions Dry Ice
USAGE For Research Use Only! Not to be used in humans


Glycogen synthase kinase-3 (GSK-3) is a serine/theronine kinase that was first characterized by its role in intermediary metabolism. In mammals, serine kinase is encoded by two related genes called GSK-3α (51 kDa) and GSK-3β (46 kDa). GSK-3 has been implicated in the regulation of the c-JuP-1 transcription factor and other intracellular signaling pathways.

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.
Morel, S. et. al. Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation. Carcinogenesis, Nov 2010; 31: 1922 - 1931
For more citations of this product click here